help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jain, S.
Right arrow Articles by Geffner, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jain, S.
Right arrow Articles by Geffner, M. E.
Endocrine Reviews 19 (5): 625-646
Copyright © 1998 by The Endocrine Society

Insulin-Like Growth Factor-I Resistance1

Suparna Jain2, David W. Golde, Robert Bailey and Mitchell E. Geffner

Memorial Sloan-Kettering Cancer Center and Cornell University Medical College (D.W.G.), New York, New York; Division of Epidemiology and Department of Anthropology (R.B.), The University of Illinois at Chicago, Chicago, Illinois; and Division of Endocrinology and Metabolism (M.E.G.), UCLA Children’s Hospital, Los Angeles, California 90095-1752

I. Introduction
II. The IGFs and Their Receptors
III. Genetically Engineered Mouse Models
IV. Malnutrition
V. Conditions Associated with Genetic IGF-I Resistance in Humans
A. African Efe Pygmies
B. Leprechaunism and other genetic disorders associated with severe insulin resistance
C. Deletions of the distal arm of chromosome 15
D. Rare examples of "idiopathic" short stature associated with elevated circulating levels of IGF-I
VI. Conditions Associated with Acquired IGF-I Resistance in Humans
A. HIV-1 infection
B. Chronic renal insufficiency
C. Mauriac syndrome
VII. Conclusions




This article has been cited by other articles:


Home page
Genome ResHome page
J. K. Pickrell, G. Coop, J. Novembre, S. Kudaravalli, J. Z. Li, D. Absher, B. S. Srinivasan, G. S. Barsh, R. M. Myers, M. W. Feldman, et al.
Signals of recent positive selection in a worldwide sample of human populations
Genome Res., May 1, 2009; 19(5): 826 - 837.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. Laviola, A. Natalicchio, S. Perrini, and F. Giorgino
Abnormalities of IGF-I signaling in the pathogenesis of diseases of the bone, brain, and fetoplacental unit in humans
Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E991 - E999.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Binder, A.-K. Seidel, D. D. Martin, R. Schweizer, C. P. Schwarze, H. A. Wollmann, T. Eggermann, and M. B. Ranke
The Endocrine Phenotype in Silver-Russell Syndrome Is Defined by the Underlying Epigenetic Alteration
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1402 - 1407.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. C. Coutinho, R. R. D. Coletta, E. M. F. Costa, P. R. Pachi, M. C. S. Boguszewski, D. Damiani, B. B. Mendonca, I. J. P. Arnhold, and A. A. L. Jorge
Polymorphisms Identified in the Upstream Core Polyadenylation Signal of IGF1 Gene Exon 6 Do Not Cause Pre- and Postnatal Growth Impairment
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4889 - 4892.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
J. Svensson, A. Tivesten, K. Sjogren, O. Isaksson, G. Bergstrom, S. Mohan, J. Molne, J. Isgaard, and C. Ohlsson
Liver-derived IGF-I regulates kidney size, sodium reabsorption, and renal IGF-II expression
J. Endocrinol., June 1, 2007; 193(3): 359 - 366.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
P. Saenger, P. Czernichow, I. Hughes, and E. O. Reiter
Small for Gestational Age: Short Stature and Beyond
Endocr. Rev., April 1, 2007; 28(2): 219 - 251.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. D. Oldroyd, Y. Miyamoto, A. Moir, T. S. Johnson, A. M. El Nahas, and J. L. Haylor
An IGF-I antagonist does not inhibit renal fibrosis in the rat following subtotal nephrectomy
Am J Physiol Renal Physiol, March 1, 2006; 290(3): F695 - F702.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W. H. Shen, J.-H. Zhou, S. R. Broussard, R. W. Johnson, R. Dantzer, and K. W. Kelley
Tumor Necrosis Factor {alpha} Inhibits Insulin-Like Growth Factor I-Induced Hematopoietic Cell Survival and Proliferation
Endocrinology, July 1, 2004; 145(7): 3101 - 3105.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Okubo, K. Siddle, H. Firth, S. O'Rahilly, L. C. Wilson, L. Willatt, T. Fukushima, S.-I. Takahashi, C. J. Petry, T. Saukkonen, et al.
Cell Proliferation Activities on Skin Fibroblasts from a Short Child with Absence of One Copy of the Type 1 Insulin-Like Growth Factor Receptor (IGF1R) Gene and a Tall Child with Three Copies of the IGF1R Gene
J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5981 - 5988.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Ducos, S. Cabrol, M. Houang, L. Perin, M. Holzenberger, and Y. Le Bouc
IGF Type 1 Receptor Ligand Binding Characteristics Are Altered in a Subgroup of Children with Intrauterine Growth Retardation
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5516 - 5524.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice
The Insulin-Related Ovarian Regulatory System in Health and Disease
Endocr. Rev., August 1, 1999; 20(4): 535 - 582.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society